 |
|
Rationale for the Use of Oral Fluoroquinolones as Empiric Treatment of Nursing Home Infections
Jack D. McCue, MD
Arch Fam Med. 1994;3(2):157-164.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Jacobson C, Strausbaugh LJ. Incidence and impact of infection in a nursing home care unit. Am J Infect Control. 1990;18:151-159.
PUBMED
2. Tresch DD, Simpson WM, Burton JR. Relationship of long-term and acute-care facilities: the problem of patient transfer and continuity of care. J Am Geriatr Soc. 1985;33:819-826.
PUBMED
3. Irvine PW, Van Buren N, Crossley K. Causes for hospitalization of nursing home patients: the role of infection. J Am Geriatr Soc. 1984;32:103-107.
PUBMED
4. Cunha BA, ed. Infectious Disease in the Elderly. Littleton, Mass: PSG Publishing Co Inc; 1988. 5. Niederman MS. Respiratory Infections in the Elderly. New York, NY: Raven Press; 1991. 6. Hazzard WR, Andres R, Bierman EL, Blass JP, eds. Principles of Geriatric Medicine and Gerontology. New York, NY: McGraw-Hill International Book Co; 1990. 7. Gleckman RA, Gant NM, eds. Infections in the Elderly. Boston, Mass: Little Brown & Co Inc; 1983. 8. Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med. 1978;298:1108-1111.
PUBMED
9. Irwin RS, Whitaker S, Pratter MR, Millard CE, Tarpey JT, Corwin RW. The transiency of oropharyngeal colonization of gram-negative bacilli in residents of a skilled nursing facility. Chest. 1982;81:31-35.
PUBMED
10. Abrutyn E, Mossey J, Levison M, Boscia J, Pittsakis P, Kaye D. Epidemiology of asymptomatic bacteriuria in elderly ambulatory nonhospitalized women. JAMA. 1987;257:1067-1071.
FREE FULL TEXT
11. Nicolle LE. Urinary tract infection in the institutionalized elderly. Infect Dis Clin Pract. 1992;1:68-71.
12. Mims AD, Norman DC, Yamamura RH, Yoshikawa TT. Clinically inapparent (asymptomatic) bacteriuria in ambulatory elderly men: epidemiological, clinical, and microbiological findings. J Am Geriatr Soc. 1990;38:1209-1214.
PUBMED
13. Galpin JE, Chow AW, Bayer AS, Guze LB. Sepsis associated with decubitus ulcers. Am J Med. 1976;61:346-350.
PUBMED
14. Lara LL, Troop PR, Beadleson-Baird M. The risk of urinary tract infection in bowel-incontinent men. J Gerontol Nurs. 1990;16:24-26.
PUBMED
15. Garibaldi RA, Brodine S, Matsumiya S. Infections among patients in nursing homes: policies, prevalence, and problems. N Engl J Med. 1981;305:731-735.
PUBMED
16. Magaziner J, Tenney JH, Deforge B, Hebel JR, Muncie HL Jr. Prevalence and characteristics of nursing-home acquired infections in the aged. J Am Geriatr Soc. 1991;39:1071-1078.
PUBMED
17. Castle SC, Norman DC, Yeh M, Miller D, Yoshikawa TT. Fever response in elderly nursing home residents: are the older truly colder? J Am Geriatr Soc. 1991;39:853-857.
PUBMED
18. Norman D, Grahn D, Yoshidawa T. Fever and aging. J Am Geriatr Soc. 1985;33:859-893.
PUBMED
19. Gleckman R, Hibert D. Afebrile bacteremia: a phenomenon in geriatric patients. JAMA. 1981;248:1478-1481.
20. Downton J, Andrews K, Puxty J. 'Silent' pyrexia in the elderly. Age Ageing. 1987;16:41-44.
FREE FULL TEXT
21. Finkelstein MS, Petkun WM, Freedman ML, Antopol SC. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc. 1983;31:19-27.
PUBMED
22. Deal WB. Unusual manifestation of infectious diseases in the aged. Geriatrics. 1979;31:77-84.
23. Marrie TJ, Durant H, Kwan C. Nursing home-acquired pneumonia: a case-control study. J Am Geriatr Soc. 1986;34:697-702.
PUBMED
24. Saltzman RL, Peterson PK. Immunodeficiency of the elderly. Rev Infect Dis. 1987;9:1127-1138.
PUBMED
25. Rosenberg JS, Gilman SC, Feldman JD. Effects of aging on cell cooperation and lymphocyte responsiveness to cytokines. J Immunol. 1983;130:1754-1758.
ABSTRACT
26. Olive KE, Berk SL. Infections in the nursing home. Clin Geriatr Med. 1992;8:821-834.
PUBMED
27. Rollins CJ, Thomson C. Nutrition. In: Bressler R, Katz MD, eds. Geriatric Pharmacology. New York, NY: McGraw-Hill International Book Co; 1993:9-39. 28. Morley JE, Mooradian AD, Silver AJ, Heber D, Alfin-Slater RB. Nutrition in the elderly. Ann Intern Med. 1988;109:890-894.
FREE FULL TEXT
29. Silver AJ, Morley JE, Strome LS, Jones D, Vickers L. Nutritional status in an academic nursing home. J Am Geriatr Soc. 1988;36:487-491.
PUBMED
30. Rudman D, Mattson DE, Nagraj HS, Caindec N, Rudman IW, Jackson DL. Antecedents of death in the men of a Veterans Administration nursing home. J Am Geriatr Soc. 1987;35:496-502.
PUBMED
31. Rudman D, Arora VD, Feller AG, Morley JE. Epidemiology of malnutrition in nursing homes. In: Morley JE, Glick Z, Rubenstein LZ, eds. Geriatric Nutrition: A Comprehensive Review. New York, NY: Raven Press; 1990:325-332. 32. Shaver HJ, Loper JA, Lutes RA. Nutritional status of nursing home patients. JPEN J Parenter Enteral Nutr. 1980;4:367-370.
FREE FULL TEXT
33. Scheckler WE, Peterson PJ. Infections and infection control among residents of eight rural Wisconsin nursing homes. Arch Intern Med. 1986;146:1981-1984.
FREE FULL TEXT
34. Setia U, Serventi I, Lorenz P. Bacteremia in a long-term care facility: spectrum and mortality. Arch Intern Med. 1984;144:1633-1635.
FREE FULL TEXT
35. Rudman D, Hontanosas A, Cohen Z, Mattson DE. Clinical correlates of bacteremia in a Veterans Administration extended care facility. J Am Geriatr Soc. 1988;6:726-732.
36. Muder RR, Brennan C, Wagener MM, Goetz AM. Bacteremia in a long-term care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis. 1992;14:647-654.
FREE FULL TEXT
37. McCue JD. Empiric antibiotic therapy for the frail elderly. Infect Dis Clin Pract. In press. 38. Finnegan TP, Austin TW, Cape RDT. A 12-month fever surveillance study in a veteran's long-stay institution. J Am Geriatr Soc. 1985;33:590-594.
PUBMED
39. Alvarez S, Shell CG, Woolley TW, Berk SL, Smith JK. Nosocomial infections in long-term facilities. J Gerontol. 1988;43:M9-M17.
ABSTRACT
40. Nicolle LE, Mclntyre M, Zacharias H, MacDonell JA. Twelve-month surveillance of infections in institutionalized men. J Am Geriatr Soc. 1984;32:513-519.
PUBMED
41. Garb JL, Brown RB, Garb JR. Differences in etiology of pneumonias in nursing home and community patients. JAMA. 1972;240:2169-2172.
42. Peterson PK, Stein D, Guay DRP, et al. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am J Med. 1988;85:164-171.
PUBMED
43. Magnuson MH, Robb SS. Nosocomial infections in a long-term care facility. Am J Infect Control. 1980;8:12-17.
PUBMED
44. Yoshikawa TT. Pneumonia, UTI, and decubiti in the nursing home: optimal management. Geriatrics. 1989;44:32-43.
PUBMED
45. Yoshikawa TT. Unique aspects of urinary tract infection in the geriatric population. Gerontology. 1984;30:339-341.
PUBMED
46. Crossley KB, Thurn JB. Nursing home-acquired pneumonia. Semin Respir Infect. 1989;4:64-72.
PUBMED
47. Gaynes RP, Weinstein RA, Chamberlin W, Kabins SA. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med. 1985;145:1804-1807.
FREE FULL TEXT
48. Dontas AS. Urinary-tract infection in nursinghome residents. In: Vergese A, Berk SL, eds. Infections in Nursing Homes and Long-term Care Facilities. Basel, Switzerland: S Karger Publishers; 1990:114. 49. Nicolle LE, Muir P, Harding GKM, Norris M. Localization of urinary tract infection in elderly, institutionalized women with asymptomatic bacteriuria. J Infect Dis. 1988;157:65-70.
FREE FULL TEXT
50. Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among nursing home patients: a prospective study. J Urol. 1987;138:1191-1195.
PUBMED
51. McCue JD. Urinary tract infections in the elderly. Pharmacotherapy. 1993;13:51S-53S.
PUBMED
52. Rowe JW. Aging, renal function and response to drugs. Aging (Milano). 1981;16:115-130.
53. Marchbanks CR, Mikolich DJ, Mayer KH, Zinner SH, Dudley MN. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections. Antimicrob Agents Chemother. 1990;34:1966-1972.
FREE FULL TEXT
54. Cox CE, Drylie DM, Klimberg I, et al. A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections. J Urol. 1989;141:575-578.
PUBMED
55. Bjork DT, Pelletier LL, Tight RR. Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients. Infect Control. 1984;5:173-180.
PUBMED
56. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
PUBMED
57. Allman RM. Pressure ulcers among the elderly. N Engl J Med. 1989;320:850-853.
PUBMED
58. Sugarman B. Pressure sores and underlying bone infection. Arch Intern Med. 1987;147:553-555.
FREE FULL TEXT
59. Bryan LS, Dew CE, Reynolds DVM. Bacteremia associated with decubitus ulcers. Arch Intern Med. 1983;143:2093-2095.
FREE FULL TEXT
60. Glenchur H, Patel BS, Pathmarajah C. Transient bacteremia associated with débridement of decubitus ulcers. Mil Med. 1981;146:432-433.
PUBMED
61. Richer M, LeBel M. Pharmacokinetics of fluoroquinolones in selected populations. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993:225-244. 62. Ball P. Adverse reactions and interactions of fluoroquinolones. Clin Invest Med. 1989;12:28-34.
PUBMED
63. Andriole VT. The Quinolones. New York, NY: Academic Press Inc; 1988. 64. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;324:384-394.
PUBMED
65. Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993. 66. Sanders WE, Sanders CC, eds. Fluoroquinolones in the Treatment of Infectious Diseases. Glenview, III: Physicians & Scientists Publishing; 1990. 67. Ciprofloxacin: major advances in intravenous and oral quinolone therapy. Am J Med. 1989;87(suppl_5A):1S-287S.
PUBMED
68. Second international symposium on new quinolones. Rev Infect Dis. 1989;11(S5):S1-S1430.
69. International symposium on new quinolones. Rev Infect Dis. 1988:10(S1):S1-S271.
PUBMED
70. Neu HC, Percival A, Lode H. Ciprofloxacin: a major advance in quinolone chemotherapy. Am J Med. 1987;82(suppl 4A):1-404.
PUBMED
71. Fostini R, Girelli M, Dalle Vedove P, Benedetti M, Recchia G. Safety profile of ofloxacin in elderly patients. Drugs Exp Clin Res. 1988;14:393-395.
PUBMED
72. Bruck K, Blomer R. Efficacy and safety of ofloxacin in elderly patients. Int J Pharmacol Res. 1987;7:195-198.
73. Paton JH, Reeves DS. Fluoroquinolone antibiotics: microbiology, pharmacokinetics and clinical use. Drugs. 1988;36:193-228.
PUBMED
74. Ofloxacin: a pharmacodynamic advance in quinolone antimicrobial therapy. Am J Med. 1989;87(suppl 6C):1S-81S.
PUBMED
75. Lomefloxacin: development of a once-a-day quinolone. Am J Med. 1992;92(suppl 4A):1S-137S.
PUBMED
76. Stuck AE, Kim DK, Frey FJ. Fleroxacin clinical pharmacokinetics. Clin Pharmacokinet. 1992;22:116-131.
PUBMED
77. Gerding DN, Hitt JA. Tissue penetration of the new quinolones in humans. Rev Infect Dis. 1989;11(suppl 5):S1046-S1057.
PUBMED
78. McCue JD. Antibiotic dosing for the renally impaired elder. P & T. In press. 79. Davey PG. Post-marketing surveillance of the quinolones: a view from Great Britain. Rev Infect Dis. 1989;11(suppl 5):S102-S107.
80. Outman WR. Enoxacin: a new fluoroquinolone antibiotic. Hosp Formulary. 1990;25:32-40.
81. Geddes AM. Safety of fleroxacin in clinical trials. Am J Med. 1993;94(suppl 3A):201S-203S.
PUBMED
82. Hooper DC, Wolfson JS. Adverse effects. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993:489-512. 83. McCue JD, Zandt J. Acute psychotic reactions associated with the use of ciprofloxacin or trimethoprin-sulfamethoxazole. Am J Med. 1991;90:528-529.
PUBMED
84. McCue JD. The advantages of simplicity in long-term care drug regimens. In: McCue JD, Tessier EG, Gaziano P, eds. Geriatric Handbook of Drug Use in Long-term Care. Baltimore, Md: Williams & Wilkins; 1993. 85. Nix DE. Drug-drug interactions with fluoroquinolone antimicrobial agents. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993:245-258. 86. Budnick LD, Schaefler S. Ciprofloxacinresistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988: The New York MRSA Study Group. Am J Public Health. 1990;80:810-813.
PUBMED
87. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;115:417-422.
FREE FULL TEXT
88. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Hancock GA. Methicillinresistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 1991;114:107-112.
FREE FULL TEXT
89. Thys JP, Jacobs F, Byl B. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1991;10:304-315.
PUBMED
90. Sanders WE, Morris JF, Alessi P, Makris AT, McCloskey RV, Trenholme GM. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with 'usual care' in a multicenter clinical trial. Am J Med. 1991;91:261-266.
PUBMED
91. Lode H, Wiley E, Olshewski P, Sievers H, Wintemantel M, Baetz R. Prospective randomized trials of new quinolones versus beta-lactam antibiotics in lower respiratory infections. Scand J Infect Dis Suppl. 1990;68:50-55.
PUBMED
92. Gentry LO. Therapy with newer oral betalactam and quinolone agents for infections of the skin and skin structures: a review. Clin Infect Dis. 1992;14:285-297.
FREE FULL TEXT
93. Mehr MR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract. 1992;34:585-591.
PUBMED
94. Trenholme GM, Schmitt GM, Spear J, Gvazdinskas LC, Levin S. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in hospital and nursing home patients with lower respiratory infections. Am J Med. 1989;87(suppl 5A):116S-118S.
PUBMED
95. Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory infections. J Am Geriatr Soc. 1991;39:979-985.
PUBMED
96. Nicolle LE, Degelau J, Alessi P, Cullison J, Meyers B. Ofloxacin use in a geriatric population. Chemotherapy. 1991;37(suppl 1):49-54.
PUBMED
97. Preheim LC, Cuevas TA, Rocaforte JS, Mellencam MA, Bittner MJ. Oral ciprofloxacin in the treatment of elderly patients with complicated UTI due to trimethoprim-sulfamethoxazole resistant bacteria. Am J Med. 1987;82:295-300.
PUBMED
98. Cox CE. Ofloxacin in the management of complicated urinary tract infection, including prostatitis. Am J Med. 1989;87(suppl 6C):61S-68S.
PUBMED
99. Cox CE, Tack KJ. Safety and efficacy of ofloxacin vs trimethoprim-sulfamethoxazole for complicated urinary tract infections. Rev Infect Dis. 1988;10(suppl 1):S175-S176.
100. Malverni R, Glauser MP. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev Infect Dis. 1988;10(suppl 1):S153-S163.
PUBMED
101. Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis. 1989;11(suppl 5):S1321-S1337.
PUBMED
102. Phillips SL, Branaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia. J Am Geriatr Soc. 1993;41:1071-1074.
PUBMED
103. Peterson PK, Stein D, Guay DR, et al. Prospective study of lower respiratory infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am J Med. 1988;85:164-171.
PUBMED
104. Fass RJ, Plouffe JF, Russell JA. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med. 1989;87(suppl 5A):136S-137S.
PUBMED
105. Snydman DR, Barza M, McGowan K, et al. Randomized comparative trial of ciprofloxacin for treatment of patients with osteomyelitis. Rev Infect Dis. 1989;11(suppl 5):S1271-S1272.
106. Thys JP, Jacobs F, Motte S. Quinolones in the treatment of lower respiratory tract infections. Rev Infect Dis. 1989;11(suppl 5):S1212-S1219.
PUBMED
107. Scully BE. Therapy of respiratory tract infections with quinolone antimicrobial agents. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993:339-362. 108. Perez-Ruvalcaba JA, Quintero-Perez NP, Morales-Reyes JJ, Huitron-Ramirez JA, Rodriguez-Chagollan JJ, Rodriguez-Noriega E. Double blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Am J Med. 1987;82:242-246.
PUBMED
109. Ramirez-Ronda CH, Saavedra S, Rivera-Vazquez CR. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin-structure infections. Am J Med. 1987;82:220-223.
PUBMED
110. Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez P. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin-structure infections: a multicenter trial. Arch Intern Med. 1989;149;2570-2583.
111. Dominguez J, Palma F, Vega ME, Magana JL, Ortiz G, Teresa-Hojyo M. Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or softtissue infections. Am J Med. 1989;87(suppl 5A):136S-137S.
PUBMED
112. Gentry LO, Koshdel A. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. Am J Med. 1989;87(suppl 5A):132S-135S.
PUBMED
113. Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections. Am J Med. 1989;87(suppl 6C):57S-60S.
PUBMED
114. McCue JD. Antibiotic selection in long-term care. In: McCue JD, Tessier ET, Gaziano P, eds. Hand-book of Drug Use for Long-term Care and the Frail Elderly. Baltimore, Md: Williams & Wilkins; 1993:28-42. 115. Trimethoprim-sulfamethoxazole revisited. Rev Infect Dis. 1982;4:196-618.
PUBMED
116. Progress and perspectives on beta-lactamase inhibition: a review of Augmentin. Postgrad Med. 1984;suppl:3-295. 117. Ceftin. Hosp Formulary. 1988;23(suppl C):1-40.
118. Borin MT. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs. 1992;42:(suppl 3):13-21.
119. Nelson JD. Cefuroxime: a cephalosporin with unique applicability to pediatric practice. Pediatr Infect Dis. 1983;2:394-396.
PUBMED
120. Cefixime: clinical overview of a new oral thirdgeneration cephalosporin. Am J Med. 1988;85(suppl 3A):1-25.
PUBMED
121. Evaluation of new oral antimicrobial agents and the experience with cefprozil: a broadspectrum oral cephalosporin. Clin Infect Dis. 1992;14(suppl 2):S1-S272.
PUBMED
122. Mott PD, Barker WH. Treatment decisions for infections occurring in nursing home residents. J Am Geriatr Soc. 1988;36:820-824.
PUBMED
123. Fabiszewski KJ, Volicer B, Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA. 1990;263:3168-3172.
FREE FULL TEXT
|
